Definium Therapeutics Inc (NASDAQ:DFTX) is among the best psychedelic stocks to buy in 2026. The company’s flagship drug ...

No statistically significant change in MADRS total score was observed with solriamfetol vs placebo in the overall study population. Topline results were announced from a phase 3 trial evaluating ...

Credit: Otsuka. At this time, the product is available to patients for a discounted price of $50; the full price is $200. Rejoyn ™, the first prescription digital therapeutic cleared for the treatment ...

Zachary Contreras of Sharp Health Plan discusses how predictive tools, artificial intelligence-driven analytics, and digital monitoring can help identify treatment-resistant depression early, enabling ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

In addition to ADHD and MDD, Axsome also is investigating Sunosi as a treatment for binge eating disorder and excessive sleepiness associated with shift work disorder. Given its novel mechanism of ...

Please provide your email address to receive an email when new articles are posted on . Spravato is the first monotherapy for adults with major depressive disorder who had an inadequate response to at ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Mendelian randomization analysis of genome-wide association study data suggests schizophrenia and major depressive disorder may cause constipation. Constipation, a common and often debilitating ...